We can make a good case right now just based on the fact that there are so many reports in the scientific and medical literature. One of the criteria for medical applications, particularly those that are therapeutic that WHO relies on is the standard randomized clinical trial. 

 

And typically a therapeutic, an antibiotic or another pharma company will go through trials that demonstrate using randomized clinical protocols the benefits of that drug. Well, HOCl has never been put into large-scale randomized controlled clinical trials. After all, it's a natural product. It's not patentable. 

 

It's not something that a drug company can bottle up and recover all its clinical trial expenses from. So it's not surprising that most of the experiences that clinicians have seen with HOCl are case reports, they're clinical series, but they're not structured in such a way that WHO can look at it and say “Yes, that’s a randomized clinical trial. It delivers data that support therapy.”

 

We feel that the case is strong enough. There are some reports, appreciable numbers in the last few years, of randomized trials, on a relatively small scale. I know of one that is being undertaken now that I think will qualify that's going to involve hundreds of patients in a randomized protocol. 

 

And I like to think that that may be the turning point that enables WHO next time around to add HOCl to the therapeutic pharmacopeia as well as the WHO disinfecting and sanitizing toolkit.

​

-- Jeffrey F. Williams, PhD, BVSc, MRCVS, microbiologist and infectious disease expert, has devoted his career to researching, inventing and bringing to market solutions that have improved the lives and health of people all over the world. 

 

-- Professor of Microbiology and Molecular Genetics, Michigan State University (Emeritus)

 

-- Elected Fellow of the American Association for the Advancement of Science (AAAS)

 

-- Holder of 30+ patents covering water treatment, disease control, odor control

 

-- Author of 200+ scientific papers and textbook chapters

 

-- Member of the Board of Counselors, National Institute of Allergy and Infectious Diseases, National Institute of Health (1984-88)

 

-- ​Chairman of a World Health Organization research committee on tropical diseases (based in Geneva) (1985-1989)

 

-- Chief Science Officer, HOCL producer that is world leader in hypochlorous acid technology and manufacturing (2014-2024)